key: cord-0750076-30namnau
authors: Giacomelli, Andrea; De Falco, Teresa; Oreni, Letizia; Pedroli, Alice; Ridolfo, Anna Lisa; Calabrò, Elisa; Carrozzo, Giorgia; Bonazzetti, Cecilia; Antinori, Spinello; Brucato, Antonio
title: Impact of gender on patients hospitalized for SARS‐COV‐2 infection: A prospective observational study
date: 2021-03-26
journal: J Med Virol
DOI: 10.1002/jmv.26933
sha: c4c891034af90e3f570c327e7e2891a42427518e
doc_id: 750076
cord_uid: 30namnau

Biological sex could affect the natural history of severe acute respiratory syndrome coronavirus 2 infection. We enrolled all COVID‐19 patients admitted to two COVID‐19 hospitals in Milan in a prospective observational study. The primary outcome was death during the study period and the secondary outcome was critical disease at hospital admission. The association(s) between clinically relevant, noncollinear variables, and the primary outcome was assessed with uni‐ and multivariable Logistic regression models. A total of 520 patients were hospitalized of whom 349 (67%) were males with a median age 61 (interquartile range: 50–72). A higher proportion of males presented critically ill when compared to females (30.1% vs. 18.7%, p < .046). Death occurred in 86 (24.6%) males and 27 (15.8%) females (p = .024). In multivariable analysis age (per 10 years more) (adjusted odds ratio [AOR]: 1.83 [95% confidence interval {CI}: 1.42–2.35], p < .0001), obesity (AOR: 2.17 [95% CI: 1.10–4.31], p = .026), critical disease at hospital admission (AOR 6.34 [95% CI: 3.50–11.48], p < .0001) were independently associated to higher odds of death whereas gender was not. In conclusion, a higher proportion of males presented critically ill at hospital admission. Age, critical disease at hospital admission, obesity, anemia, D‐dimer, estimated glomerular filtration rate, lactate dehydrogenase, and creatine kinase predicted death in hospitalized COVID‐19 patients.

Since the beginning of the COVID-19 pandemic it appeared clearly from the first Chinese reports that a higher proportion of males required hospital admission when compared to females. 1 A similar pattern was also observed in Italy in a significantly older population when compared to the Chinese one. [2] [3] [4] In addition, according to the Italian official reports, males accounted for the majority of COVID-19 related death in all age categories except for those aged above 90 years of age. 5 Sero-epidemiological studies conducted in the general population showed how gender does not seem to provide a different susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, whereas different demographic, cultural and behavioral factors appeared to be the main determinants of SARS-CoV-2 infection. [6] [7] [8] Consequently, it could be speculated that gender could affect the natural history of SARS-CoV-2 infection by means of a higher likelihood to progress to severe disease requiring hospitalization in males.

We aimed to assess the impact of gender on disease severity at hospital admission and mortality of COVID-19 hospitalized patients during the first wave of the Italian epidemic. The primary outcome was death during the study period and the secondary outcome was critical disease at hospital admission, the life status of the patients discharged before the censoring date was ascertained by means of telephone calls made by two physicians.

The descriptive statistics include proportions for categorical variable, and median values and interquartile range (IQR) for continuous variables.

The baseline demographic and clinic-epidemiological characteristics of females and males were compared using χ 2 or Fisher's exact test where necessary for categorical variables and Wilcoxon's rank-sum test for continuous variables.

Kaplan-Meier curves were built to assess the time dependent probability of death in males and females and further stratified by disease severity at hospital admission (critical vs. noncritical disease).

The association(s) between clinically relevant, noncollinear variables and the primary and secondary outcome was assessed by means of uni-and multivariable Logistic regression models. The multivariable analysis was made by introducing into the model the variables that found to be significantly associated with outcome in the univariate analysis, as well as potential confounders.

The analysis on the primary outcome (death) was repeated after restricting only to males and females.

All of the statistical analyses were made using SAS software, version 9.4, and differences with p values of less than .05 were considered statistical significant.

A total of 520 patients were hospitalized of whom 349 (67%) were males with a median age 61 (IQR: 50-72) ( During the time of observation death occurred in 86 (24.6%) males and 27 (15.8%) females (p = .024) ( Figure S1A) . A trend toward a higher survival probability in critically ill females when compared to males was observed (p = .094) ( Figure S1B ). In multivariable analysis male gender did not resulted independently associated to death ( 

In our study we observed a male to female ratio of hospitalized COVID-19 patients of 2:1 which is in line with previous reports which suggested a different gender susceptibility in the requirement of hospital care despite a similar between genders infection risk. 10, 11 Moreover, we observed that males more frequently presented with a critical disease. This finding is in line with a recent meta-analysis by severity is intriguing and it has been supported by epidemiological 14 and echological studies. 15 In particular, in line with our observation In particular, most countries with available data indicate a male to female case fatality ratio higher than 1, ranging up to 3.5 in some cases. 16 The differences observed in the between gender case fatality rate in different countries are mainly driven by the different sociodemographic characteristics of these countries. In particular, as mentioned above for Italy males accounted for a higher proportion of COVID-19 death until the age of 80 when the demographic patients. These findings are in line with previous report suggesting a higher inflammation in males when compared to females with SARS-CoV-2 infection partially explaining the observed worse outcomes in males. 17, 18 Our study accounts for several limitations. First, the study was conducted in a daily evolving scenario with multiple pharmacological intervention often in compassionate use. Nevertheless, no significant differences in pharmacological interventions were observed between males and females. Second, the setting and the characteristics of patients were that of the "first wave" of the Italian pandemic and thus not completely generalizable to that of the current "second pandemic wave."

In the end, the data for influenza vaccination were not retrievable for 17.7% of patients and consequently a chance finding related to bias, such as the presence of unmeasured confounders, could not be definitely excluded. Nevertheless, the models were run also without influenza as a variable and the output was overall comparable with that reported in the present manuscript (data not shown).

In conclusion, a higher proportion of males presented critically ill at hospital admission after SARS-CoV-2 infection. Nevertheless, in our multivariable model male gender did not resulted independently associated to death and other correlated factors were identified such as age, critical disease at hospital admission, obesity, anemia, D-dimer, eGFR, LDH and CK. In addition, influenza vaccination in the 2019-2020 season resulted associated to a lower odds of critical presentation at hospital admission. Although preliminary, our observation of an association between influenza vaccination and COVID-19 severity at hospital admission warrant further investigation in observational studies assessing COVID-19 outcomes.

The authors would like to thank all of the patients and their families and all of the medical staff (paramedics, nurses, and physicians) who are making every effort to ensure the best care for patients suffering from COVID-19. FADOI (Italian Federation of Hospital Internists) gave a grant to partially support the study.

Andrea Giacomelli has received consultancy fees from Mylan and nonfinancial educational support from Gilead.

All authors were involved in writing this manuscript, approved the final version as submitted, and have agreed to be accountable for all aspects of it.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The study was approved by our local IRB (Comitato Etico Interaziendale Area 1).

Clinical characteristics of coronavirus disease 2019 in China

Brusaferro S Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study

Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening

Self-reported symptoms of SARS-CoV-2 infection in a nonhospitalized population in Italy: crosssectional study of the EPICOVID19 web-based survey

Sex and gender differences in the outcome of patients with COVID-19

Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study

COVID-19: the gendered impacts of the outbreak

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: data from the EPICOVID19 Web-Based Survey. Vaccines (Basel)

Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil

Relationship between influenza vaccination coverage rate and COVID-19 outbreak: an Italian ecological study. Vaccines (Basel)

Sex differences in COVID-19 case fatality: do we know enough?

Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator

Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study

All patients signed a written informed consent.

http://orcid.org/0000-0003-3685-4289